Financing
Loci Orthopaedics announces €12.8m series A financing
July 17, 2024Business Services Financing, Musculo-skeletal disorder, investment, loci orthopaedics
Loci Orthopaedics has announced the successful closing of an oversubscribed €12.8m series A financing, which was led by new investors …
Renalys Pharma closes ¥6bn series A financing for kidney disease treatments in Asia
July 17, 2024Business Services Financing, Nephrology, kidney disease, renalys Pharma
Renalys Pharma has announced that it has completed ¥6bn series A financing, which was led by Catalys Pacific and SR …
PureTech Health launches Seaport Therapeutics
April 9, 2024Business Services Financing, Neurology, PureTech Health, launch
PureTech Health has announced key progress on its ‘strategic initiatives to deliver innovative medicines to patients and unlock value for …
Avalyn Pharma raises $175m in Series C financing for inhalation therapies
September 28, 2023Business Services Avalyn Pharma, Financing, Pharmacy, funding, inhalation therapies
US-based clinical stage biopharmaceutical company Avalyn Pharma has announced that it has raised $175m in Series C financing to continue …
Renibus Therapeutics announces $47m financing for phase 3 trial
July 19, 2023Business Services Cardiology, Financing, Renibus Therapeutics, clinical trial
Clinical stage biopharmaceutical company Renibus Therapeutics has announced that it has raised $47m from the initial closing of its Series …
ElevateBio announced $401m in Series D financing for cell and gene therapies
May 25, 2023Sales and Marketing ElevateBio, Financing, cell and gene therapies
US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …
Nido Biosciences raises $109m in funding for neurological diseases treatments
May 16, 2023Sales and Marketing Financing, Neurology, Nido Biosciences, funding, neurology
US-based clinical-stage company Nido Biosciences has announced that is has received $109m in Seed, Series A and Series B financings, …
Adagio raises $336 million to advance COVID-19 antibody
April 20, 2021Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news
Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
